(function(doc, html, url) {
var widget = doc.createElement("div");
widget.innerHTML = html;
var script = doc.currentScript; // e = a.currentScript;
if (!script) {
var scripts = doc.scripts;
for (var i = 0; i < scripts.length; ++i) {
script = scripts[i];
if (script.src && script.src.indexOf(url) != -1) break;
}
}
script.parentElement.replaceChild(widget, script);
}(document, '
Different Responses to Loud, Clear, and Slow Speech in Parkinson’s Disease
What is it about?
Many people with Parkinson’s disease develop dysarthria, a motor speech disorder that negatively affects communication. Current behavioral interventions often use speech-cueing strategies, such as “speak louder,” “speak clearly,” or “speak more slowly,” to improve speech. Although these strategies have been shown to be effective, not everyone with Parkinson’s disease benefits in the same way. In this study, we examined how individuals with Parkinson’s disease responded to these three speech cues. We found that responses varied widely. We also found that specific speech features present during habitual speech were linked to how well someone responded to a given cue. These findings suggest that speech treatment for Parkinson’s disease should move toward a more personalized approach rather than relying on a one-size-fits-all model.
Why is it important?
Although speech cueing strategies are widely used in clinical practice, clinicians have limited guidance on how to select the most effective approach for an individual with Parkinson’s disease. Most prior research has focused on group averages, which can overlook important individual differences. The current study is important because it highlights the variability in how individuals respond to the speech cues. By identifying perceptual speech features associated with positive or negative responses to specific cues, this work moves toward more personalized treatment guidelines. Ultimately, helping clinicians choose the most appropriate speech strategy may lead to more efficient therapy, improved communication, and better quality of life for individuals living with Parkinson’s disease.